In recent trading session, Cognition Therapeutics Inc (NASDAQ:CGTX) saw 0.44 million shares changing hands at last check today with its beta currently measuring 1.00. Company’s
Cognition Therapeutics Inc (NASDAQ:CGTX) has a beta value of 1.00 and has seen 1.81 million shares traded in the last trading session. The company, currently
Cognition Therapeutics Inc (NASDAQ:CGTX) has a beta value of 1.00 and has seen 1.5 million shares traded in the recent trading session. The company, currently
During the last session, Cognition Therapeutics Inc (NASDAQ:CGTX)’s traded shares were 0.43 million, with the beta value of the company hitting 0.98. At the end
In today’s recent session, 0.4 million shares of the Cognition Therapeutics Inc (NASDAQ:CGTX) have been traded, and its beta is 0.96. Most recently the company’s
Cognition Therapeutics Inc (NASDAQ:CGTX)’s traded shares stood at 0.56 million during the last session, with the company’s beta value hitting 1.00. At the close of
In last trading session, Cognition Therapeutics Inc (NASDAQ:CGTX) saw 1.6 million shares changing hands with its beta currently measuring 1.01. Company’s recent per share price
In the last trading session, 1.47 million shares of the Cognition Therapeutics Inc (NASDAQ:CGTX) were traded, and its beta was 1.02. Most recently the company’s
Cognition Therapeutics Inc (NASDAQ:CGTX)’s traded shares stood at 2.46 million during the last session, with the company’s beta value hitting 1.01. At the close of
Cognition Therapeutics Inc (NASDAQ:CGTX)’s traded shares stood at 41.45 million during the last session, with the company’s beta value hitting 1.01. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
